Literature DB >> 17702735

Rise of pay for performance: implications for care of people with chronic kidney disease.

Amar A Desai1, Alan M Garber, Glenn M Chertow.   

Abstract

Many health care providers and policy makers believe that health care financing systems fail to reward high-quality care. In recent years, federal and private payers have begun to promote pay for performance, or value-based purchasing, initiatives to raise the quality of care. This report describes conceptual issues in the design and implementation of pay for performance for chronic kidney disease and ESRD care. It also considers the implications of recent ESRD payment policy changes on the broader goals of pay for performance. Congressionally mandated bundle payment demonstration for dialysis, newly implemented case-mix adjustment of the composite rate, and G codes for the monthly capitation payment are important opportunities to understand facility and provider behavior with particular attention to patient selection and treatment practices. Well-designed payment systems will reward quality care for patients while maintaining appropriate accountability and fairness for health care providers.

Entities:  

Mesh:

Year:  2007        PMID: 17702735     DOI: 10.2215/CJN.00510107

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  6 in total

Review 1.  Biomarkers and health-related quality of life in end-stage renal disease: a systematic review.

Authors:  Brennan M R Spiegel; Gil Melmed; Sean Robbins; Eric Esrailian
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-01       Impact factor: 8.237

2.  Is there "cherry picking" in the ESRD Program? Perceptions from a Dialysis Provider Survey.

Authors:  Amar A Desai; Roger Bolus; Allen Nissenson; Glenn M Chertow; Sally Bolus; Matthew D Solomon; Osman S Khawar; Jennifer Talley; Brennan M R Spiegel
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-01       Impact factor: 8.237

3.  Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study.

Authors:  Ming-Yen Lin; Li-Jen Cheng; Yi-Wen Chiu; Hui-Min Hsieh; Ping-Hsun Wu; Yi-Ting Lin; Shu-Li Wang; Feng-Xuan Jian; Chih Cheng Hsu; Shu-An Yang; Huei-Lan Lee; Shang-Jyh Hwang
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

4.  Patient and provider factors associated with enrolment in the pre-end-stage renal disease pay-for-performance programme in Taiwan: a cross-sectional study.

Authors:  Hsiao-Yun Hu; Feng-Xuan Jian; Yun-Ju Lai; Yung-Feng Yen; Nicole Huang; Shang Jyh Hwang
Journal:  BMJ Open       Date:  2019-09-13       Impact factor: 2.692

5.  Association of pre-ESRD care education with patient outcomes in a 10-year longitudinal study of patients with CKD stages 3-5 in Taiwan.

Authors:  Yung-Ho Hsu; Wu-Chien Chien; Chu-Lin Chou; Chi-Hsiang Chung; Hui-Wen Chiu; Chia-Te Liao; Chia-Chao Wu
Journal:  Sci Rep       Date:  2021-11-19       Impact factor: 4.379

6.  Early winners and losers in dialysis center pay-for-performance.

Authors:  Milda R Saunders; Haena Lee; Marshall H Chin
Journal:  BMC Health Serv Res       Date:  2017-12-08       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.